BMF anticorps (AA 2-14)

N° du produit ABIN1732353

Cet anticorps anti-BMF est un anticorps Lapin Polyclonal détectant BMF dans WB, IHC (p) et ICC. Adapté pour Humain.

Aperçu rapide pour BMF anticorps (AA 2-14) (ABIN1732353)

Antigène: BMF (Bcl2 Modifying Factor (BMF))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp BMF est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC)

Détail du produit anti-BMF anticorps

Épitope: AA 2-14

Specificité: Reacts with the N-terminus part of human Bmf.

Purification: Purified

Immunogène: Peptide corresponding to aa 2-14 of human Bmf (accession no. NP_277038).

Isotype: IgG

Information d'application

Indications d'application: Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
WB (2 μg/mL) ICC (10 μg/mL)

Restrictions: For Research Use only

Stockage

Buffer: PBS, pH 7.4

Conseil sur la manipulation: Dilute in PBS or medium that is identical to that used in the assay system.

Stock: -20 °C

Stockage commentaire: Stable for at least one year at -20°C. Avoid multiple freeze-thaw cycles.

Date de péremption: 12 months

Détails sur BMF

Antigène: BMF (Bcl2 Modifying Factor (BMF))

Autre désignation: Bmf

Sujet: In healthy cells, Bmf associates with the dynein light chain 2 component of the myosin V motors and is sequestered by the cell's actin cytoskeleton. Disruption of the actin cytoskeleton, either by depolymerization of actin filaments or by detachment of cells from the extracellular matrix, triggers release and activation of Bmf, initiating the downstream apoptotic program. Bmf is constitutively expressed in many tissues.

Bcl-2-modifying factor Bcl 2-modifying factor Gene name: BMF

ID gène: 90427

UniProt: Q96LC9